Production (Stage)
BioMarin Pharmaceutical Inc.
BMRN
$58.11
$0.560.97%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 21.57% | 5.95% | -17.36% | 4.56% | -9.16% |
| Total Receivables | 16.01% | 4.23% | 35.82% | 13.28% | 6.56% |
| Inventory | 12.03% | 11.33% | 14.26% | 21.33% | 23.84% |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 11.18% | 42.54% | -24.71% | -17.05% | -5.71% |
| Total Current Assets | 16.18% | 9.35% | 3.43% | 10.49% | 5.03% |
|
|
|||||
| Total Current Assets | 16.18% | 9.35% | 3.43% | 10.49% | 5.03% |
| Net Property, Plant & Equipment | -2.62% | -3.18% | -2.04% | -1.35% | -0.72% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -11.55% | 0.64% | -13.74% | -14.44% | -14.21% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -1.36% | -0.07% | 2.71% | 5.29% | 4.26% |
| Total Assets | 3.99% | 2.15% | 1.38% | 7.68% | 6.82% |
|
|
|||||
| Total Accounts Payable | 0.52% | -25.39% | 3.63% | -7.39% | 10.37% |
| Total Accrued Expenses | 6.30% | 6.33% | 20.16% | 19.25% | 9.85% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -98.75% | -98.49% | -98.40% | 5,995.08% | 5,336.50% |
| Total Finance Division Other Current Liabilities | 58.57% | -30.80% | -32.95% | -58.43% | -62.80% |
| Total Other Current Liabilities | 58.57% | -30.80% | -32.95% | -58.43% | -62.80% |
| Total Current Liabilities | -42.25% | -48.43% | -38.48% | 78.71% | 81.85% |
|
|
|||||
| Total Current Liabilities | -42.25% | -48.43% | -38.48% | 78.71% | 81.85% |
| Long-Term Debt | 0.34% | 0.34% | 0.34% | -45.24% | -45.24% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -18.01% | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 10.51% | 19.26% | 20.92% | 21.66% | 26.98% |
| Total Liabilities | -24.76% | -29.58% | -22.75% | 0.03% | 1.36% |
|
|
|||||
| Common Stock & APIC | 3.11% | 3.39% | 3.56% | 3.69% | 3.72% |
| Retained Earnings | 98.31% | 68.68% | 50.21% | 37.61% | 27.83% |
| Treasury Stock & Other | 162.56% | 230.48% | -70.87% | 152.14% | 38.34% |
| Total Common Equity | 14.18% | 14.27% | 10.55% | 10.53% | 8.90% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 14.18% | 14.27% | 10.55% | 10.53% | 8.90% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 14.18% | 14.27% | 10.55% | 10.53% | 8.90% |
|
|
|||||